The Administrative Office of the HCCC provides efficient, broad-based administrative support to the HCCC's Director, senior leadership, program leaders, shared resources resource directors, and HCCC members. The role of the Administrative Office is to provide infrastructure to facilitate all HCCC research functions including: 1) Strategic Planning, 2) Communications, 3) Research Programs Support, 4) Shared Research Resources Oversight, 5) Financial Management, 6) Research Education, 7) Space Utilization and Construction, and 8) Linkages with the Iowa Cancer Consortium. The HCCC functions administratively as a matrix cancer center with administrative staff providing support to 187 HCCC members with over $41.3 million in peer reviewed funding, including $17.9 million from the NCI and $14.8 million in non-peer reviewed funding. HCCC administration leverages the expertise of its team members while operating in an innovative and efficient manner. New initiatives supported since the last grant cycle include 1) Operationalizing two new shared research resources, 2) Transitioning to the newly configured research programs, 3) Deploying two new seed grants (Cancer and Aging Pilot grants and Pathways to Accelerate Cancer Therapeutics), 4) Converting to electronic submission and award of grants, 5) Strengthening inter-programmatic interactions and educational offerings by organizing new forums such as the HCCC Research Retreat which hosts over 250 attendees, 6) Advancing research education with the formation of the HCCC Education Committee and promoting STEM education events throughout the State, and 7) Promoting communication throughout the HCCC and catchment area with new social media tools. HCCC Senior Leadership Senior leadership supports the Director of the Cancer Center in defining and implementing the strategic vision. Members of the senior leadership team include: Director, George Weiner, MD; Deputy Director for Research, Michael Henry, PhD; Associate Director for Basic Research, Gail Bishop, PhD; Interim Associate Director for Clinical Research, Kimberly Leslie, MD; Associate Director for Population Science, Elizabeth Chrischilles, PhD; Associate Director for Administration, Tina Devery, MHA; and Assistant Director for Education, Jon Houtman, PhD. This team establishes a vision for the HCCC and addresses overall goals, policies and operations. Together they foster cancer discovery and translation, and integrate education, at multiple levels, into the HCCC. Through interdisciplinary collaboration and coordination, senior leadership identifies and supports cancer research that is applicable to the catchment area of the HCCC, which is the State of Iowa.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-20
Application #
9914234
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
20
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Reiner, Anne S; Sisti, Julia; John, Esther M et al. (2018) Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 36:1513-1520
Liu, Q; Kulak, M V; Borcherding, N et al. (2018) A novel HER2 gene body enhancer contributes to HER2 expression. Oncogene 37:687-694
Arthur, Rhonda; Wassertheil-Smoller, Sylvia; Manson, JoAnn E et al. (2018) The Combined Association of Modifiable Risk Factors with Breast Cancer Risk in the Women's Health Initiative. Cancer Prev Res (Phila) 11:317-326
Press, Robert H; Shu, Hui-Kuo G; Shim, Hyunsuk et al. (2018) The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective. Int J Radiat Oncol Biol Phys 102:1219-1235
Viala, Marie; Chiba, Akiko; Thezenas, Simon et al. (2018) Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study. BMC Cancer 18:770
Madsen, Mark T; Menda, Yusuf; O'Dorisio, Thomas M et al. (2018) Technical Note: Single time point dose estimate for exponential clearance. Med Phys 45:2318-2324
Luchtel, Rebecca A; Dasari, Surendra; Oishi, Naoki et al. (2018) Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. Blood 132:1386-1398
Sabree, Shakoora; Berg, Daniel; Sato, Mariko (2018) Treatment of a pediatric patient with MET-amplified signet ring cell adenocarcinoma of the stomach with crizotinib. Pediatr Blood Cancer 65:e26984
Bharti, Sanjay Kumar; Sommers, Joshua A; Awate, Sanket et al. (2018) A minimal threshold of FANCJ helicase activity is required for its response to replication stress or double-strand break repair. Nucleic Acids Res 46:6238-6256
Zeliadt, Steven B; Hoffman, Richard M; Birkby, Genevieve et al. (2018) Challenges Implementing Lung Cancer Screening in Federally Qualified Health Centers. Am J Prev Med 54:568-575

Showing the most recent 10 out of 1080 publications